Skip to main content

Table 1 Baseline patient characteristics and test results

From: Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome

Characteristic

Pre-implementation (n = 26)

Post-implementation (n = 11)

p-value

Median age at first visit, years (range)

43.5 (16–82)

52 (5–85)

0.316

Sex (%)

 Male

17 (65.4)

7 (63.6)

 

 Female

9 (34.6)

4 (36.4)

1.000

Strongyloides serological test (%)

 Positive

20 (76.9)

9 (81.8)

 

 Indeterminate

5 (19.2)

2 (18.2)

 

 Negative

1 (3.9)

0 (0.0)

1.000

Stool ova and parasite test (%)

 Larvae detected

5 (19.2)

3 (27.3)

 

 Negative

16 (61.6)

5 (45.4)

 

 Not tested

5 (19.2)

3 (27.3)

0.694

Eosinophiliac (%)

 Median eosinophil count (bil/L)

0.20a

0.38b

0.930

 Positive

9 (34.6)

4 (36.4)

 

 Negative

16 (61.5)

6 (54.5)

 

 Not tested

1 (3.9)

1 (9.1)

0.857

Type of infectiond (%)

 Simple intestinal

25 (96.1)

8 (72.7)

 

 Hyperinfection

1 (3.9)

3 (27.3)

0.070

  1. aOne patient with no eosinophil value
  2. bTwo patients with no eosinophil values
  3. ceosinophil count > 0.4 × 109/L
  4. das defined by the CATMAT guidelines [4]